ICAAC 50th

Title Content type
Bridging Human Drug Exposure with In Vivo Pk-PD Modeling for Determination of CLSI, EUCAST, and E-Test Breakpoints of Posaconazole (POS) and Aspergillus fumigatus (AF) (click for details)
Influence on Outcome of the Empirical Use of Broad Spectrum Antifungal Agents in Patients with Hematological Malignances Admitted in an ICU Due to a Severe Infection (click for details)
The Investigational Metalloenzyme Inhibitors VT-1129 and VT-1161 Have Potent In Vitro Activity against Cryptococcus Species (click for details)
Effect of Different Molecular Sizes of Mannan as Vaccines against Invasive Aspergillosis (click for details)
Development of an In Vitro Polymicrobial (PM) Biofilm Model with Aspergillus fumigatus (AF) and Pseudomonas aeruginosa (PA) (click for details)
Two Year Experience of Posaconazole (POS) Prophylaxis during the First 100 Days in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients (click for details)
A New Resistance Mechanism from Environmental Origin Conferring to Voriconazole Resistance has Emerged in Clinical Aspergillus fumigatus Isolates in the Netherlands (click for details)
Phosphoinositide8208;Dependent Kinase 1 (PDK1) Inhibitors are a Novel Class of Cell Wall8208;Targeted Antifungal Small Molecules (click for details)
Performance of the Beta-D-Glucan in HSCT Recipients with Positive Serum Galactomannan (click for details)
Efficacy of Caspofungin, Amphotericin B and Fluconazole against Candida albicans Biofilms under Conditions of Flow (click for details)


Subscribe to ICAAC 50th